Chat with us
Research Assistance
Online
  • Please enter your first name.

Europe Tissue Diagnostics Market Size & Outlook, 2026-2033

The tissue diagnostics market in Europe is expected to reach a projected revenue of US$ 5,370.3 million by 2033. A compound annual growth rate of 9.5% is expected of Europe tissue diagnostics market from 2026 to 2033.

  • Clinical Diagnostics
    • Tissue Diagnostics
      • Tissue Diagnostics Market Outlook
Revenue, 2025 (US$M)
$2,632.6
Estimate, 2026 (US$M)
$2,846.2
Forecast, 2033 (US$M)
$5,370.3
CAGR, 2026 - 2033
9.5%
Europe Tissue Diagnostics Market, 2021-2033 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Prism AI by Grand View ResearchFree to try

Ask a question about the tissue diagnostics market

Every figure cited from GVR research

Europe tissue diagnostics market highlights

  • The Europe tissue diagnostics market generated a revenue of USD 2,632.6 million in 2025.
  • The market is expected to grow at a CAGR of 9.5% from 2026 to 2033.
  • In terms of segment, hospitals was the largest revenue generating end use in 2025.
  • CRO is the most lucrative end use segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2026 to 2033.


Europe data book summary

Market revenue in 2025USD 2,632.6 million
Market revenue in 2033USD 5,370.3 million
Growth rate9.5% (CAGR from 2026 to 2033)
Largest segmentHospitals
Fastest growing segmentCRO
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationDiagnostic center, Hospitals, CRO, Pharmaceutical Organizations
Key market players worldwideRoche Holding AG ADR, Abbott Laboratories, Thermo Fisher Scientific Inc, Siemens AG, Danaher Corp, BioMerieux SA, Qiagen NV, BD, Merck KGaA, GE Aerospace, Agilent Technologies Inc, Biogenex, Cell Signaling Technology, Bio SB, DiaGenic


Other key industry trends

  • In terms of revenue, Europe region accounted for 28.1% of the global tissue diagnostics market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 3,811.0 million by 2033.

European market is the second largest market in terms of revenue and is expected to witness significant growth in the forecast period. Companies in Europe are involved in extensive research on cancer and more specifically in development of advanced techniques for cancer detection.

Discovery of new cancer-related genes, studying tumor heterogeneity, and identification of alterations that contribute to tumorigenesis. The above factors are expected to increase the revenue generated from this region. Cancer is a public health burden across the European Union. 

The European market is expected to grow owing to rise in aging population coupled with increase in access to healthcare. In August 2021, Unilabs, a Swiss company, in collaboration with Ibex Medical Analytics announced the launch of new AIpowered digital pathology platform across 16 European countries.

No credit card required*

Publish Date: Jun 12, 2026

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Tissue Diagnostics Market Companies

NameProfile# EmployeesHQWebsite
Roche Holding AG ADRView profile 103,605Grenzacherstrasse 124, Basel, Switzerland, 4070www.roche.com
Merck KGaAView profile 62,345Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293www.emdgroup.com
Abbott LaboratoriesView profile 114,000100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400www.abbottinvestor.com
BioMerieux SAView profile 13,982Marcy l’Etoile, Lyon, France, 69280www.biomerieux.com
Siemens AGView profile 321,000Werner-von-Siemens-Strabe 1, Munich, BY, Germany, 80333www.siemens.com
GE AerospaceView profile 125,000One Financial Center, Suite 3700, Boston, MA, United States, 02111www.geaerospace.com
Thermo Fisher Scientific IncView profile 122,000168 Third Avenue, Waltham, MA, United States, 02451www.thermofisher.com
Danaher CorpView profile 63,0002200 Pennsylvania Avenue, N.W., Suite 800W, Washington, DC, United States, 20037-1701www.danaher.com
Agilent Technologies IncView profile 17,7005301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051www.agilent.com
Qiagen NVView profile 5,900Hulsterweg 82, Venlo, LI, Netherlands, 5912 PLwww.qiagen.com

Europe Tissue Diagnostics Market Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Tissue Diagnostics Market Outlook will help companies and investors design strategic landscapes.


Hospitals was the largest segment with a revenue share of 40.71% in 2025.

Horizon Databook has segmented the Europe tissue diagnostics market based on diagnostic center, hospitals, cro, pharmaceutical organizations covering the revenue growth of each sub-segment from 2021 to 2033.




European market is the second largest market in terms of revenue and is expected to witness significant growth in the forecast period. Companies in Europe are involved in extensive research on cancer and more specifically in development of advanced techniques for cancer detection.

Discovery of new cancer-related genes, studying tumor heterogeneity, and identification of alterations that contribute to tumorigenesis. The above factors are expected to increase the revenue generated from this region. Cancer is a public health burden across the European Union. 

The European market is expected to grow owing to rise in aging population coupled with increase in access to healthcare. In August 2021, Unilabs, a Swiss company, in collaboration with Ibex Medical Analytics announced the launch of new AIpowered digital pathology platform across 16 European countries.

  • Europe Tissue Diagnostics Market End use Outlook (Revenue, USD Million , 2021-2033)
    • Diagnostic center
    • Hospitals
    • CRO
    • Pharmaceutical Organizations
  • Europe Tissue Diagnostics Market Technology Outlook (Revenue, USD Million , 2021-2033)
    • Immunohistochemistry
    • In situ Hybridization
    • Primary & Special Staining
    • Digital Pathology and Workflow
    • Anatomic Pathology
    • Molecular Pathology
  • Europe Tissue Diagnostics Market Application Outlook (Revenue, USD Million , 2021-2033)
    • Non Small Cell Lung Cancer
    • Other Cancers
    • Gastric Cancer
    • Breast Cancer
    • Prostate Cancer
  • Europe Tissue Diagnostics Market Modality Outlook (Revenue, USD Million , 2021-2033)
    • Pharma / CRO / Research market
    • Clinical market

Reasons to subscribe to Tissue Diagnostics Market Outlook databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Tissue Diagnostics Market Outlook databook

  • Our clientele includes a mix of Tissue Diagnostics Market Outlook companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Tissue Diagnostics Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Tissue Diagnostics Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Europe Tissue Diagnostics Market, 2021-2033 (US$M)

No Access Stack Chart

Europe End Use - Tissue Diagnostics Market Statistics, 2025 - 2033 (US$M)

No Access Pie Chart

Europe tissue diagnostics market statistics, by country, 2021-2033 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more